Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CUPR research report →
About the company
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.
- CEO
- Yong Qi Quek
- IPO
- 2025
- Employees
- 15
- HQ
- Singapore, SG
Price Chart
- Market Cap
- $15.47M
- P/E
- -4.05
- P/S
- 400.40
- P/B
- 3.77
- EV/EBITDA
- -3.80
- Div Yield
- 0.00%
- Gross Margin
- -1.29%
- Op Margin
- -9154.62%
- Net Margin
- -9366.75%
- ROE
- -1569.05%
- ROIC
- -82.48%
- Revenue
- $49.89K · 3.26%
- Net Income
- $-4,673,447 · -199.48%
- EPS
- $-1.84 · -220.78%
- Op Income
- $-4,567,604
- FCF YoY
- -630.78%
- 52W High
- $76.00
- 52W Low
- $1.76
- 50D MA
- $3.15
- 200D MA
- $4.47
- Beta
- -1.09
- Avg Volume
- 3.35M
Get TickerSpark's AI analysis on CUPR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | CHAN Tat Jing | other | 0 |
| Mar 18, 26 | QUEK David Yong Qi | other | 0 |
| Mar 18, 26 | KOH Pee Keat | other | 0 |
| Mar 18, 26 | TEO Peng Kwang | other | 0 |
| Mar 18, 26 | RAINA Natasha Kaur | other | 0 |
| Mar 18, 26 | LEE Jimmy Peng Siew | other | 0 |
| Mar 18, 26 | NG Wei Chean | other | 0 |
Our CUPR coverage
Recent articles, reports, and earnings notes.
No research on CUPR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CUPR report →Similar companies
Peers in the same neighborhood.